title: Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis.
authors.forename: M
authors.initials: M
authors.lastname: Sallée
authors.forename: E
authors.initials: E
authors.lastname: Crétel
authors.forename: R
authors.initials: R
authors.lastname: Jean
authors.forename: L
authors.initials: L
authors.lastname: Chiche
authors.forename: M
authors.initials: M
authors.lastname: Bourlière
authors.forename: P
authors.initials: P
authors.lastname: Poullin
authors.forename: P
authors.initials: P
authors.lastname: Lefèvre
authors.forename: J-M
authors.initials: JM
authors.lastname: Durand
mesh_terms: D051722:ADAM Proteins / Q000276:immunology; D000071120:ADAMTS13 Protein; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007155:Immunologic Factors / Q000009:adverse effects*; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D014841:von Willebrand Factor / Q000276:immunology
chemical_list: D000998:Antiviral Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D016898:Interferon-alpha; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human